Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FQ2LW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,756
Award facts
- Contract value 100% obligated
- $28,755.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,755.70 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems under DLA's procurement authority.
This award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, including specialty pharmaceuticals and brand-name drugs across multiple therapeutic domains to support military healthcare programs worldwide. Ozempic, a diabetes medication, aligns with AmerisourceBergen's demonstrated portfolio of therapeutic product deliveries and reflects the company's established capability to fulfill federal medical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DB25FQ2LW?
SPE2DB25FQ2LW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FQ2LW worth?
The government has obligated $28,756 on SPE2DB25FQ2LW.
Is contract SPE2DB25FQ2LW an order under another contract?
Yes. SPE2DB25FQ2LW is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ2LW competed?
The extent of competition for SPE2DB25FQ2LW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award